SPONSOR
The Lymphoma Academic Research Organisation
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Lymphoma, Mantle-CellPeripheral T Cell LymphomaRelapse/RecurrenceHematopathology Eligible or CAR-t Cell Treatment
NCT06558604 Phase 2
Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Lymphoma, Mantle-Cell
NCT04984837 Phase 2
Recruiting
Study of Lacutamab in Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
NCT04328298
Recruiting
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Hematopathology Eligible or CAR-t Cell Treatment